Compile Data Set for Download or QSAR
Report error Found 506 Enz. Inhib. hit(s) with all data for entry = 11779
TargeteIF-2-alpha kinase GCN2(Human)
Dong-A St Co.

US Patent
LigandPNGBDBM646970(US20240025884, Example 181)
Affinity DataIC50: 10nMAssay Description:384-well (Greiner #784075) (or 1536-well [Greiner #782075]) plates containing 60 nl (or 20 nl for 1536-well) of compound in 100% DMSO (10 concentrati...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2024
Entry Details
Go to US Patent

TargeteIF-2-alpha kinase GCN2(Human)
Dong-A St Co.

US Patent
LigandPNGBDBM646971(US20240025884, Example 182)
Affinity DataIC50: 10nMAssay Description:384-well (Greiner #784075) (or 1536-well [Greiner #782075]) plates containing 60 nl (or 20 nl for 1536-well) of compound in 100% DMSO (10 concentrati...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2024
Entry Details
Go to US Patent

TargeteIF-2-alpha kinase GCN2(Human)
Dong-A St Co.

US Patent
LigandPNGBDBM646972(US20240025884, Example 183)
Affinity DataIC50: 10nMAssay Description:384-well (Greiner #784075) (or 1536-well [Greiner #782075]) plates containing 60 nl (or 20 nl for 1536-well) of compound in 100% DMSO (10 concentrati...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2024
Entry Details
Go to US Patent

TargeteIF-2-alpha kinase GCN2(Human)
Dong-A St Co.

US Patent
LigandPNGBDBM646966(US20240025884, Example 177)
Affinity DataIC50: 10nMAssay Description:384-well (Greiner #784075) (or 1536-well [Greiner #782075]) plates containing 60 nl (or 20 nl for 1536-well) of compound in 100% DMSO (10 concentrati...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2024
Entry Details
Go to US Patent

TargeteIF-2-alpha kinase GCN2(Human)
Dong-A St Co.

US Patent
LigandPNGBDBM646967(US20240025884, Example 178)
Affinity DataIC50: 10nMAssay Description:384-well (Greiner #784075) (or 1536-well [Greiner #782075]) plates containing 60 nl (or 20 nl for 1536-well) of compound in 100% DMSO (10 concentrati...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2024
Entry Details
Go to US Patent

TargeteIF-2-alpha kinase GCN2(Human)
Dong-A St Co.

US Patent
LigandPNGBDBM646968(US20240025884, Example 179)
Affinity DataIC50: 10nMAssay Description:384-well (Greiner #784075) (or 1536-well [Greiner #782075]) plates containing 60 nl (or 20 nl for 1536-well) of compound in 100% DMSO (10 concentrati...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2024
Entry Details
Go to US Patent

TargeteIF-2-alpha kinase GCN2(Human)
Dong-A St Co.

US Patent
LigandPNGBDBM646977(US20240025884, Example 188)
Affinity DataIC50: 10nMAssay Description:384-well (Greiner #784075) (or 1536-well [Greiner #782075]) plates containing 60 nl (or 20 nl for 1536-well) of compound in 100% DMSO (10 concentrati...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2024
Entry Details
Go to US Patent

TargeteIF-2-alpha kinase GCN2(Human)
Dong-A St Co.

US Patent
LigandPNGBDBM646978(US20240025884, Example 189)
Affinity DataIC50: 10nMAssay Description:384-well (Greiner #784075) (or 1536-well [Greiner #782075]) plates containing 60 nl (or 20 nl for 1536-well) of compound in 100% DMSO (10 concentrati...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2024
Entry Details
Go to US Patent

TargeteIF-2-alpha kinase GCN2(Human)
Dong-A St Co.

US Patent
LigandPNGBDBM646979(US20240025884, Example 190)
Affinity DataIC50: 10nMAssay Description:384-well (Greiner #784075) (or 1536-well [Greiner #782075]) plates containing 60 nl (or 20 nl for 1536-well) of compound in 100% DMSO (10 concentrati...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2024
Entry Details
Go to US Patent

TargeteIF-2-alpha kinase GCN2(Human)
Dong-A St Co.

US Patent
LigandPNGBDBM646980(US20240025884, Example 191)
Affinity DataIC50: 10nMAssay Description:384-well (Greiner #784075) (or 1536-well [Greiner #782075]) plates containing 60 nl (or 20 nl for 1536-well) of compound in 100% DMSO (10 concentrati...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2024
Entry Details
Go to US Patent

TargeteIF-2-alpha kinase GCN2(Human)
Dong-A St Co.

US Patent
LigandPNGBDBM646974(US20240025884, Example 185)
Affinity DataIC50: 10nMAssay Description:384-well (Greiner #784075) (or 1536-well [Greiner #782075]) plates containing 60 nl (or 20 nl for 1536-well) of compound in 100% DMSO (10 concentrati...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2024
Entry Details
Go to US Patent

TargeteIF-2-alpha kinase GCN2(Human)
Dong-A St Co.

US Patent
LigandPNGBDBM646975(US20240025884, Example 186)
Affinity DataIC50: 10nMAssay Description:384-well (Greiner #784075) (or 1536-well [Greiner #782075]) plates containing 60 nl (or 20 nl for 1536-well) of compound in 100% DMSO (10 concentrati...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2024
Entry Details
Go to US Patent

TargeteIF-2-alpha kinase GCN2(Human)
Dong-A St Co.

US Patent
LigandPNGBDBM646976(US20240025884, Example 187)
Affinity DataIC50: 10nMAssay Description:384-well (Greiner #784075) (or 1536-well [Greiner #782075]) plates containing 60 nl (or 20 nl for 1536-well) of compound in 100% DMSO (10 concentrati...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2024
Entry Details
Go to US Patent

TargeteIF-2-alpha kinase GCN2(Human)
Dong-A St Co.

US Patent
LigandPNGBDBM646953(US20240025884, Example 164)
Affinity DataIC50: 10nMAssay Description:384-well (Greiner #784075) (or 1536-well [Greiner #782075]) plates containing 60 nl (or 20 nl for 1536-well) of compound in 100% DMSO (10 concentrati...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2024
Entry Details
Go to US Patent

TargeteIF-2-alpha kinase GCN2(Human)
Dong-A St Co.

US Patent
LigandPNGBDBM646954(US20240025884, Example 165)
Affinity DataIC50: 10nMAssay Description:384-well (Greiner #784075) (or 1536-well [Greiner #782075]) plates containing 60 nl (or 20 nl for 1536-well) of compound in 100% DMSO (10 concentrati...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2024
Entry Details
Go to US Patent

TargeteIF-2-alpha kinase GCN2(Human)
Dong-A St Co.

US Patent
LigandPNGBDBM646955(US20240025884, Example 166)
Affinity DataIC50: 10nMAssay Description:384-well (Greiner #784075) (or 1536-well [Greiner #782075]) plates containing 60 nl (or 20 nl for 1536-well) of compound in 100% DMSO (10 concentrati...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2024
Entry Details
Go to US Patent

TargeteIF-2-alpha kinase GCN2(Human)
Dong-A St Co.

US Patent
LigandPNGBDBM646949(US20240025884, Example 160)
Affinity DataIC50: 10nMAssay Description:384-well (Greiner #784075) (or 1536-well [Greiner #782075]) plates containing 60 nl (or 20 nl for 1536-well) of compound in 100% DMSO (10 concentrati...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2024
Entry Details
Go to US Patent

TargeteIF-2-alpha kinase GCN2(Human)
Dong-A St Co.

US Patent
LigandPNGBDBM646950(US20240025884, Example 161)
Affinity DataIC50: 10nMAssay Description:384-well (Greiner #784075) (or 1536-well [Greiner #782075]) plates containing 60 nl (or 20 nl for 1536-well) of compound in 100% DMSO (10 concentrati...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2024
Entry Details
Go to US Patent

TargeteIF-2-alpha kinase GCN2(Human)
Dong-A St Co.

US Patent
LigandPNGBDBM646951(US20240025884, Example 162)
Affinity DataIC50: 10nMAssay Description:384-well (Greiner #784075) (or 1536-well [Greiner #782075]) plates containing 60 nl (or 20 nl for 1536-well) of compound in 100% DMSO (10 concentrati...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2024
Entry Details
Go to US Patent

TargeteIF-2-alpha kinase GCN2(Human)
Dong-A St Co.

US Patent
LigandPNGBDBM646952(US20240025884, Example 163)
Affinity DataIC50: 10nMAssay Description:384-well (Greiner #784075) (or 1536-well [Greiner #782075]) plates containing 60 nl (or 20 nl for 1536-well) of compound in 100% DMSO (10 concentrati...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2024
Entry Details
Go to US Patent

TargeteIF-2-alpha kinase GCN2(Human)
Dong-A St Co.

US Patent
LigandPNGBDBM646961(US20240025884, Example 172)
Affinity DataIC50: 10nMAssay Description:384-well (Greiner #784075) (or 1536-well [Greiner #782075]) plates containing 60 nl (or 20 nl for 1536-well) of compound in 100% DMSO (10 concentrati...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2024
Entry Details
Go to US Patent

TargeteIF-2-alpha kinase GCN2(Human)
Dong-A St Co.

US Patent
LigandPNGBDBM646962(US20240025884, Example 173)
Affinity DataIC50: 10nMAssay Description:384-well (Greiner #784075) (or 1536-well [Greiner #782075]) plates containing 60 nl (or 20 nl for 1536-well) of compound in 100% DMSO (10 concentrati...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2024
Entry Details
Go to US Patent

TargeteIF-2-alpha kinase GCN2(Human)
Dong-A St Co.

US Patent
LigandPNGBDBM646963(US20240025884, Example 174)
Affinity DataIC50: 10nMAssay Description:384-well (Greiner #784075) (or 1536-well [Greiner #782075]) plates containing 60 nl (or 20 nl for 1536-well) of compound in 100% DMSO (10 concentrati...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2024
Entry Details
Go to US Patent

TargeteIF-2-alpha kinase GCN2(Human)
Dong-A St Co.

US Patent
LigandPNGBDBM646964(US20240025884, Example 175)
Affinity DataIC50: 10nMAssay Description:384-well (Greiner #784075) (or 1536-well [Greiner #782075]) plates containing 60 nl (or 20 nl for 1536-well) of compound in 100% DMSO (10 concentrati...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2024
Entry Details
Go to US Patent

TargeteIF-2-alpha kinase GCN2(Human)
Dong-A St Co.

US Patent
LigandPNGBDBM646957(US20240025884, Example 168)
Affinity DataIC50: 10nMAssay Description:384-well (Greiner #784075) (or 1536-well [Greiner #782075]) plates containing 60 nl (or 20 nl for 1536-well) of compound in 100% DMSO (10 concentrati...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2024
Entry Details
Go to US Patent

TargeteIF-2-alpha kinase GCN2(Human)
Dong-A St Co.

US Patent
LigandPNGBDBM646958(US20240025884, Example 169)
Affinity DataIC50: 10nMAssay Description:384-well (Greiner #784075) (or 1536-well [Greiner #782075]) plates containing 60 nl (or 20 nl for 1536-well) of compound in 100% DMSO (10 concentrati...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2024
Entry Details
Go to US Patent

TargeteIF-2-alpha kinase GCN2(Human)
Dong-A St Co.

US Patent
LigandPNGBDBM646959(US20240025884, Example 170)
Affinity DataIC50: 10nMAssay Description:384-well (Greiner #784075) (or 1536-well [Greiner #782075]) plates containing 60 nl (or 20 nl for 1536-well) of compound in 100% DMSO (10 concentrati...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2024
Entry Details
Go to US Patent

TargeteIF-2-alpha kinase GCN2(Human)
Dong-A St Co.

US Patent
LigandPNGBDBM646960(US20240025884, Example 171)
Affinity DataIC50: 10nMAssay Description:384-well (Greiner #784075) (or 1536-well [Greiner #782075]) plates containing 60 nl (or 20 nl for 1536-well) of compound in 100% DMSO (10 concentrati...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2024
Entry Details
Go to US Patent

TargeteIF-2-alpha kinase GCN2(Human)
Dong-A St Co.

US Patent
LigandPNGBDBM647001(US20240025884, Example 212)
Affinity DataIC50: 10nMAssay Description:384-well (Greiner #784075) (or 1536-well [Greiner #782075]) plates containing 60 nl (or 20 nl for 1536-well) of compound in 100% DMSO (10 concentrati...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2024
Entry Details
Go to US Patent

TargeteIF-2-alpha kinase GCN2(Human)
Dong-A St Co.

US Patent
LigandPNGBDBM647002(US20240025884, Example 213)
Affinity DataIC50: 10nMAssay Description:384-well (Greiner #784075) (or 1536-well [Greiner #782075]) plates containing 60 nl (or 20 nl for 1536-well) of compound in 100% DMSO (10 concentrati...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2024
Entry Details
Go to US Patent

TargeteIF-2-alpha kinase GCN2(Human)
Dong-A St Co.

US Patent
LigandPNGBDBM647003(US20240025884, Example 214)
Affinity DataIC50: 10nMAssay Description:384-well (Greiner #784075) (or 1536-well [Greiner #782075]) plates containing 60 nl (or 20 nl for 1536-well) of compound in 100% DMSO (10 concentrati...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2024
Entry Details
Go to US Patent

TargeteIF-2-alpha kinase GCN2(Human)
Dong-A St Co.

US Patent
LigandPNGBDBM647004(US20240025884, Example 215)
Affinity DataIC50: 10nMAssay Description:384-well (Greiner #784075) (or 1536-well [Greiner #782075]) plates containing 60 nl (or 20 nl for 1536-well) of compound in 100% DMSO (10 concentrati...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2024
Entry Details
Go to US Patent

TargeteIF-2-alpha kinase GCN2(Human)
Dong-A St Co.

US Patent
LigandPNGBDBM646997(US20240025884, Example 208)
Affinity DataIC50: 10nMAssay Description:384-well (Greiner #784075) (or 1536-well [Greiner #782075]) plates containing 60 nl (or 20 nl for 1536-well) of compound in 100% DMSO (10 concentrati...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2024
Entry Details
Go to US Patent

TargeteIF-2-alpha kinase GCN2(Human)
Dong-A St Co.

US Patent
LigandPNGBDBM647000(US20240025884, Example 211)
Affinity DataIC50: 10nMAssay Description:384-well (Greiner #784075) (or 1536-well [Greiner #782075]) plates containing 60 nl (or 20 nl for 1536-well) of compound in 100% DMSO (10 concentrati...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2024
Entry Details
Go to US Patent

TargeteIF-2-alpha kinase GCN2(Human)
Dong-A St Co.

US Patent
LigandPNGBDBM647005(US20240025884, Example 216)
Affinity DataIC50: 10nMAssay Description:384-well (Greiner #784075) (or 1536-well [Greiner #782075]) plates containing 60 nl (or 20 nl for 1536-well) of compound in 100% DMSO (10 concentrati...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2024
Entry Details
Go to US Patent

TargeteIF-2-alpha kinase GCN2(Human)
Dong-A St Co.

US Patent
LigandPNGBDBM647006(US20240025884, Example 217)
Affinity DataIC50: 10nMAssay Description:384-well (Greiner #784075) (or 1536-well [Greiner #782075]) plates containing 60 nl (or 20 nl for 1536-well) of compound in 100% DMSO (10 concentrati...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2024
Entry Details
Go to US Patent

TargeteIF-2-alpha kinase GCN2(Human)
Dong-A St Co.

US Patent
LigandPNGBDBM647007(US20240025884, Example 218)
Affinity DataIC50: 10nMAssay Description:384-well (Greiner #784075) (or 1536-well [Greiner #782075]) plates containing 60 nl (or 20 nl for 1536-well) of compound in 100% DMSO (10 concentrati...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2024
Entry Details
Go to US Patent

TargeteIF-2-alpha kinase GCN2(Human)
Dong-A St Co.

US Patent
LigandPNGBDBM647008(US20240025884, Example 219)
Affinity DataIC50: 10nMAssay Description:384-well (Greiner #784075) (or 1536-well [Greiner #782075]) plates containing 60 nl (or 20 nl for 1536-well) of compound in 100% DMSO (10 concentrati...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2024
Entry Details
Go to US Patent

TargeteIF-2-alpha kinase GCN2(Human)
Dong-A St Co.

US Patent
LigandPNGBDBM646985(US20240025884, Example 196)
Affinity DataIC50: 10nMAssay Description:384-well (Greiner #784075) (or 1536-well [Greiner #782075]) plates containing 60 nl (or 20 nl for 1536-well) of compound in 100% DMSO (10 concentrati...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2024
Entry Details
Go to US Patent

TargeteIF-2-alpha kinase GCN2(Human)
Dong-A St Co.

US Patent
LigandPNGBDBM646986(US20240025884, Example 197)
Affinity DataIC50: 10nMAssay Description:384-well (Greiner #784075) (or 1536-well [Greiner #782075]) plates containing 60 nl (or 20 nl for 1536-well) of compound in 100% DMSO (10 concentrati...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2024
Entry Details
Go to US Patent

TargeteIF-2-alpha kinase GCN2(Human)
Dong-A St Co.

US Patent
LigandPNGBDBM646987(US20240025884, Example 198)
Affinity DataIC50: 10nMAssay Description:384-well (Greiner #784075) (or 1536-well [Greiner #782075]) plates containing 60 nl (or 20 nl for 1536-well) of compound in 100% DMSO (10 concentrati...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2024
Entry Details
Go to US Patent

TargeteIF-2-alpha kinase GCN2(Human)
Dong-A St Co.

US Patent
LigandPNGBDBM646988(US20240025884, Example 199)
Affinity DataIC50: 10nMAssay Description:384-well (Greiner #784075) (or 1536-well [Greiner #782075]) plates containing 60 nl (or 20 nl for 1536-well) of compound in 100% DMSO (10 concentrati...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2024
Entry Details
Go to US Patent

TargeteIF-2-alpha kinase GCN2(Human)
Dong-A St Co.

US Patent
LigandPNGBDBM646981(US20240025884, Example 192)
Affinity DataIC50: 10nMAssay Description:384-well (Greiner #784075) (or 1536-well [Greiner #782075]) plates containing 60 nl (or 20 nl for 1536-well) of compound in 100% DMSO (10 concentrati...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2024
Entry Details
Go to US Patent

TargeteIF-2-alpha kinase GCN2(Human)
Dong-A St Co.

US Patent
LigandPNGBDBM646982(US20240025884, Example 194 | US20240025884, Exampl...)
Affinity DataIC50: 10nMAssay Description:384-well (Greiner #784075) (or 1536-well [Greiner #782075]) plates containing 60 nl (or 20 nl for 1536-well) of compound in 100% DMSO (10 concentrati...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2024
Entry Details
Go to US Patent

TargeteIF-2-alpha kinase GCN2(Human)
Dong-A St Co.

US Patent
LigandPNGBDBM646982(US20240025884, Example 194 | US20240025884, Exampl...)
Affinity DataIC50: 10nMAssay Description:384-well (Greiner #784075) (or 1536-well [Greiner #782075]) plates containing 60 nl (or 20 nl for 1536-well) of compound in 100% DMSO (10 concentrati...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2024
Entry Details
Go to US Patent

TargeteIF-2-alpha kinase GCN2(Human)
Dong-A St Co.

US Patent
LigandPNGBDBM646993(US20240025884, Example 204)
Affinity DataIC50: 10nMAssay Description:384-well (Greiner #784075) (or 1536-well [Greiner #782075]) plates containing 60 nl (or 20 nl for 1536-well) of compound in 100% DMSO (10 concentrati...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2024
Entry Details
Go to US Patent

TargeteIF-2-alpha kinase GCN2(Human)
Dong-A St Co.

US Patent
LigandPNGBDBM646994(US20240025884, Example 205)
Affinity DataIC50: 10nMAssay Description:384-well (Greiner #784075) (or 1536-well [Greiner #782075]) plates containing 60 nl (or 20 nl for 1536-well) of compound in 100% DMSO (10 concentrati...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2024
Entry Details
Go to US Patent

TargeteIF-2-alpha kinase GCN2(Human)
Dong-A St Co.

US Patent
LigandPNGBDBM646995(US20240025884, Example 206)
Affinity DataIC50: 10nMAssay Description:384-well (Greiner #784075) (or 1536-well [Greiner #782075]) plates containing 60 nl (or 20 nl for 1536-well) of compound in 100% DMSO (10 concentrati...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2024
Entry Details
Go to US Patent

TargeteIF-2-alpha kinase GCN2(Human)
Dong-A St Co.

US Patent
LigandPNGBDBM646996(US20240025884, Example 207)
Affinity DataIC50: 10nMAssay Description:384-well (Greiner #784075) (or 1536-well [Greiner #782075]) plates containing 60 nl (or 20 nl for 1536-well) of compound in 100% DMSO (10 concentrati...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2024
Entry Details
Go to US Patent

TargeteIF-2-alpha kinase GCN2(Human)
Dong-A St Co.

US Patent
LigandPNGBDBM646989(US20240025884, Example 200)
Affinity DataIC50: 10nMAssay Description:384-well (Greiner #784075) (or 1536-well [Greiner #782075]) plates containing 60 nl (or 20 nl for 1536-well) of compound in 100% DMSO (10 concentrati...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2024
Entry Details
Go to US Patent

Displayed 1 to 50 (of 506 total ) | Next | Last >>
Jump to: